Ophthotech Corp is a biopharmaceutical company specializing in the development of novel therapeutics to treat diseases of the back of the eye with a focus on developing therapeutics for age-related macular degeneration.


Updates from The Motley Fool

Latest updates on Ophthotech from Fool.com.


Stock Performance

View Interactive OPHT Charts
Sponsored by

Key Data Points

Primary metrics and data points about Ophthotech.
Current Price: $34.40
Prev Close: $32.19
Open: $32.47
Bid: $34.45
Ask: $44.90
Day's Range: $32.22 - $35.28
52wk Range: $29.85 - $80.00
Volume: 1,010,584
Avg Vol 1,037,964
Market Cap: $1B
P/E (ttm): -6.97
EPS (ttm): ($4.62)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Ophthotech.
CAPS Rating 2 out of 5
 
46 Outperform
6 Underperform
CAPS All Stars
 
6 Outperform
4 Underperform

How do you think Ophthotech will perform against the market?



You pick for Ophthotech is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Ophthotech.

Ophthotech Corp is a biopharmaceutical company specializing in the development of novel therapeutics to treat diseases of the back of the eye with a focus on developing therapeutics for age-related macular degeneration.

  • Exchange: NASDAQ